BLOG

neumo
  • HOME
  • Products and Services
  • Blog
  • About
  • 日本語
  • English
  • 

May 26, 2018

Ryosei Wakabayashi presented at Nomura Securities on May 25, 2018

Ryosei Wakabayashi presented the newest neuroscience and neuroscience business to investors.

 


  • Twitter
  • Facebook
  • Pin it
  • LinkedIn
  • B!Hatena
  • LINE
  • LINE

Ryosei Wakabayashi presented at KPMG AZSA LLC on May 18, 2018
Next

Ryosei Wakabayashi presented at Startup Hub Tokyo on March 2nd, 2018
Prev

Related Posts

Thumbnail of related posts 096

The Brains Behind Leadership

With Mark Zuckerberg testifying before C ...

Thumbnail of related posts 004

Neuroscience is Becoming the MVP in Sports Strategy

Neymar has Soccer on the Brain A fascina ...

Thumbnail of related posts 004

Ryosei Wakabayashi served as a moderator at a real-time neurofeedback conference on November 27, 2017

Ryosei Wakabayashi served as a moderator ...

Thumbnail of related posts 176

Ryosei Wakabayashi presented at KPMG AZSA LLC on May 18, 2018

     

Thumbnail of related posts 075

NeuroTechX Is Making the Global Local: An Interview with Co-Founder & Executive Director Yannick Roy

In recent years we have seen the explosi ...

  • HOME
  • Products and Services
  • Blog
  • About

Copyright © 2025 neumo ブレインテック・音×脳神経科学で人類の可能性を最大化する All Rights Reserved.

 PAGE TOP
当サイトでは利便性向上や閲覧の追跡のためにGoogle・他提携サービスによりCookieが使用されています。サイトの閲覧を続けた場合Cookieの使用に同意したことになります。
承諾する
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
SAVE & ACCEPT